Education
About Us
Working with TipRanks
Follow Us
Peter Winston Lewis Insider Profile
4 Followers
Peter Winston Lewis, Director at RepliCel Life Sciences, holds 1.00M shares in RepliCel Life Sciences (Ticker: REPCF).
Peter Winston Lewis RepliCel Life Sciences (REPCF)Director
RepliCel Life Sciences (REPCF)
Director
Ranked #101,695 out of 106,487 Corporate Insiders
Profitable Transactions
0 out of 9 Profitable Transactions
Average Return
-47.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Peter Winston Lewis does not currently own shares as a corporate insider.
A breakdown of Peter Winston Lewis's holdings
Insider Roles
Director
Roles that Peter Winston Lewis holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 19, 2019 - Jan 19, 2020
Return:-23.30%
The most profitable trade made by Peter Winston Lewis
Peter Winston Lewis's Trading History
List of latest transactions for each holding click on a transaction to see Peter Winston Lewis's performance on stock
You May Also Like
Peter Winston Lewis insider profile FAQ
What is the percentage of profitable transactions made by Peter Winston Lewis?
The percentage of profitable transactions made by Peter Winston Lewis is 0%.
What is the average return per transaction made by Peter Winston Lewis?
The average return per transaction made by Peter Winston Lewis is -47.50%.
What stocks does Peter Winston Lewis hold?
Peter Winston Lewis holds: REPCF stocks.
What was Peter Winston Lewis’s latest transaction?
Peter Winston Lewis latest transaction was an Uninformative Buy of ―.
What was Peter Winston Lewis's most profitable transaction?
Peter Winston Lewis’s most profitable transaction was an Informative Buy of REPCF stock on January 19, 2019. The return on the trade was -23.30%.
What is Peter Winston Lewis's role in RepliCel Life Sciences?
Peter Winston Lewis's role in RepliCel Life Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.